Catalyst Wire Dossier Catalyst Wire Dossier

ATG-Fresenius

anti-thymocyte globulin · Fresenius Biotech
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ATG-Fresenius, covering 2011-12-12 to 2016-04-05. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia [NA]

See pricing